The Patent Finder

Cortendo AB

Also on record
Records under this name other than patents Cortendo AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Cortendo AB

PatentTitleStatus Expires Confidence
US 6,166,017Method of using ketoconazole and related substances in medicaments for treatment of type II diabetes and methods of treating same
Term ended
Term ended Dec 14, 2018 · From the USPTO record
Term endedTerm ended Dec 14, 2018From the USPTO record
US 7,872,008Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor
Term ended
Term ended Apr 29, 2016 · From the USPTO record
Term endedTerm ended Apr 29, 2016From the USPTO record
US 7,960,410Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor
Lapsed on the fee record
Ended Jun 14, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jun 14, 2015From the USPTO record
US 7,217,505Method for determining whether condition is symptom of metabolic syndrome
Lapsed on the fee record
Ended May 15, 2015 · From the USPTO record
Lapsed on the fee recordEnded May 15, 2015From the USPTO record
US 6,642,236Methods for prophylactic treatment of cardiovascular disease with inhibitor of cortisol synthesis
Term ended
Ended no later than Aug 9, 2014 · From the USPTO record
Term endedEnded no later than Aug 9, 2014From the USPTO record
US 6,410,339Preparation for diagnosis of the metabolic syndrome and diseases including the syndrome
Lapsed on the fee record
Ended Jun 25, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jun 25, 2014From the USPTO record
US 6,274,582Preparation for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
Lapsed on the fee record
Ended Aug 14, 2013 · From the USPTO record
Lapsed on the fee recordEnded Aug 14, 2013From the USPTO record
US 6,881,739Use of cortisol antagonists in the treatment of heart failure
Lapsed on the fee record
Ended Apr 19, 2013 · From the USPTO record
Lapsed on the fee recordEnded Apr 19, 2013From the USPTO record
US 5,849,740Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes
Term ended
Term ended no later than Dec 15, 2018 · Low confidence
Term endedTerm ended no later than Dec 15, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited